Her en super god oversigt fra Evaluate Vantage med laegemiddel-kandidater, som FDA har vendt tomlen op og ned til i august:
https://www.evaluate.com/vantage/articles/news/snippets/us-fda-approval-tracker-august
Supplementary and other notable approval decisions in August
Darzalex (+ Kyprolis + dexamethasone) J&J/Genmab Relapsed/refractory multiple myeloma (Candor) Approved
https://www.evaluate.com/vantage/articles/news/snippets/us-fda-approval-tracker-august
Supplementary and other notable approval decisions in August
Darzalex (+ Kyprolis + dexamethasone) J&J/Genmab Relapsed/refractory multiple myeloma (Candor) Approved